Article Details

Avirmax Biopharma Announces First Patient Dosed in Clinical Trial of ABI-110, a ... - Yahoo Finance

Retrieved on: 2024-11-21 23:22:15

Tags for this article:

Click the tags to see associated articles and topics

Avirmax Biopharma Announces First Patient Dosed in Clinical Trial of ABI-110, a ... - Yahoo Finance. View article details on hiswai:

Excerpt

Avirmax Biopharma, Inc., a leader in the development of innovative gene therapies, today announced that the first patient has been successfully ...

Article found on: finance.yahoo.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo